Department of Pharmacology, Faculty of Pharmacy (V.M., E.F.-N., M.P.), János Szentágothai Research Centre (V.M., E.F.-N., M.P.), Department of Pharmacognosy, Faculty of Pharmacy (T.B.), and Department of Pharmacology and Pharmacotherapy, Medical School (B.Z.Z., C.H.), University of Pécs, Pécs, Hungary; and Membrane Protein Research Group (O.U., É.B., C.Ö.-L.) and Biomembrane Research Group (K.K., Á.T.), Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Department of Pharmacology, Faculty of Pharmacy (V.M., E.F.-N., M.P.), János Szentágothai Research Centre (V.M., E.F.-N., M.P.), Department of Pharmacognosy, Faculty of Pharmacy (T.B.), and Department of Pharmacology and Pharmacotherapy, Medical School (B.Z.Z., C.H.), University of Pécs, Pécs, Hungary; and Membrane Protein Research Group (O.U., É.B., C.Ö.-L.) and Biomembrane Research Group (K.K., Á.T.), Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary
Drug Metab Dispos. 2020 Oct;48(10):1064-1073. doi: 10.1124/dmd.120.000085. Epub 2020 Jul 13.
Chrysin is an abundant flavonoid in nature, and it is also contained by several dietary supplements. Chrysin is highly biotransformed in the body, during which conjugated metabolites chrysin-7-sulfate and chrysin-7-glucuronide are formed. These conjugates appear at considerably higher concentrations in the circulation than the parent compound. Based on previous studies, chrysin can interact with biotransformation enzymes and transporters; however, the interactions of its metabolites have been barely examined. In this in vitro study, the effects of chrysin, chrysin-7-sulfate, and chrysin-7-glucuronide on cytochrome P450 enzymes (2C9, 2C19, 3A4, and 2D6) as well as on organic anion-transporting polypeptides (OATPs; 1A2, 1B1, 1B3, and 2B1) and ATP binding cassette [P-glycoprotein, multidrug resistance-associated protein 2, and breast cancer resistance protein (BCRP)] transporters were investigated. Our observations revealed that chrysin conjugates are strong inhibitors of certain biotransformation enzymes (e.g., CYP2C9) and transporters (e.g., OATP1B1, OATP1B3, OATP2B1, and BCRP) examined. Therefore, the simultaneous administration of chrysin-containing dietary supplements with medications needs to be carefully considered due to the possible development of pharmacokinetic interactions. SIGNIFICANCE STATEMENT: Chrysin-7-sulfate and chrysin-7-glucuronide are the major metabolites of flavonoid chrysin. In this study, we examined the effects of chrysin and its conjugates on cytochrome P450 enzymes and on organic anion-transporting polypeptides and ATP binding cassette transporters (P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2). Our results demonstrate that chrysin and/or its conjugates can significantly inhibit some of these proteins. Since chrysin is also contained by dietary supplements, high intake of chrysin may interrupt the transport and/or the biotransformation of drugs.
白杨素是一种天然存在的丰富黄酮类化合物,也存在于几种膳食补充剂中。白杨素在体内高度生物转化,在此过程中形成共轭代谢物白杨素-7-硫酸盐和白杨素-7-葡萄糖醛酸苷。这些共轭物在循环中的浓度明显高于母体化合物。基于以前的研究,白杨素可以与生物转化酶和转运体相互作用;然而,其代谢物的相互作用几乎没有被研究过。在这项体外研究中,研究了白杨素、白杨素-7-硫酸盐和白杨素-7-葡萄糖醛酸苷对细胞色素 P450 酶(2C9、2C19、3A4 和 2D6)以及有机阴离子转运多肽(OATPs;1A2、1B1、1B3 和 2B1)和 ATP 结合盒[P-糖蛋白、多药耐药相关蛋白 2 和乳腺癌耐药蛋白 (BCRP)]转运体的影响。我们的观察结果表明,白杨素共轭物是某些生物转化酶(如 CYP2C9)和转运体(如 OATP1B1、OATP1B3、OATP2B1 和 BCRP)的强抑制剂。因此,由于可能发生药代动力学相互作用,需要谨慎考虑同时给予含有白杨素的膳食补充剂和药物。意义陈述:白杨素-7-硫酸盐和白杨素-7-葡萄糖醛酸苷是黄酮类白杨素的主要代谢物。在这项研究中,我们研究了白杨素及其共轭物对细胞色素 P450 酶以及有机阴离子转运多肽和 ATP 结合盒转运体(P-糖蛋白、乳腺癌耐药蛋白和多药耐药相关蛋白 2)的影响。我们的结果表明,白杨素和/或其共轭物可以显著抑制其中一些蛋白质。由于膳食补充剂中也含有白杨素,因此大量摄入白杨素可能会中断药物的转运和/或生物转化。